report cover

HIV Integrase Strand Transfer Inhibitors (INSTI) Market - Global Outlook and Forecast 2022-2028

  • 13 May 2022
  • Life Sciences
  • 102 Pages
  • Report code : 24WT-7068969

HIV Integrase Strand Transfer Inhibitors Market

1 Introduction to Research & Analysis Reports
1.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Overall Market Size
2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size: 2021 VS 2028
2.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players in Global Market
3.2 Top Global HIV Integrase Strand Transfer Inhibitors (INSTI) Companies Ranked by Revenue
3.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Companies
3.4 Top 3 and Top 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Integrase Strand Transfer Inhibitors (INSTI) Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Integrase Strand Transfer Inhibitors (INSTI) Players in Global Market
3.6.1 List of Global Tier 1 HIV Integrase Strand Transfer Inhibitors (INSTI) Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV Integrase Strand Transfer Inhibitors (INSTI) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Markets, 2021 & 2028
4.1.2 Raltegravir
4.1.3 Elvitegravir Combination Drugs
4.1.4 Dolutegravir and Its Combination Drug
4.1.5 Bictegravir Combination Drug
4.1.6 Cabotegravir
4.1.7 Other
4.2 By Type - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue & Forecasts
4.2.1 By Type - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2022
4.2.2 By Type - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2023-2028
4.2.3 By Type - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Drug Center
5.1.5 Other
5.2 By Application - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue & Forecasts
5.2.1 By Application - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2022
5.2.2 By Application - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2023-2028
5.2.3 By Application - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2021 & 2028
6.2 By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue & Forecasts
6.2.1 By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2022
6.2.2 By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2023-2028
6.2.3 By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2028
6.3.2 US HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.3.3 Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.3.4 Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2028
6.4.2 Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.4.3 France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.4.4 U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.4.5 Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.4.6 Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.4.7 Nordic Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.4.8 Benelux HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2028
6.5.2 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.5.3 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.5.4 South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.5.5 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.5.6 India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2028
6.6.2 Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.6.3 Argentina HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2028
6.7.2 Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.7.3 Israel HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.7.4 Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
6.7.5 UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, 2017-2028
7 Players Profiles
7.1 Adcock Ingram Limited
7.1.1 Adcock Ingram Limited Corporate Summary
7.1.2 Adcock Ingram Limited Business Overview
7.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.1.4 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.1.5 Adcock Ingram Limited Key News
7.2 Affine Formulations Limited
7.2.1 Affine Formulations Limited Corporate Summary
7.2.2 Affine Formulations Limited Business Overview
7.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.2.4 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.2.5 Affine Formulations Limited Key News
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Corporate Summary
7.3.2 Aurobindo Pharma Business Overview
7.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.3.4 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.3.5 Aurobindo Pharma Key News
7.4 Biocon Limited
7.4.1 Biocon Limited Corporate Summary
7.4.2 Biocon Limited Business Overview
7.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.4.4 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.4.5 Biocon Limited Key News
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Corporate Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.5.4 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.5.5 Bristol-Myers Squibb Key News
7.6 Cipla
7.6.1 Cipla Corporate Summary
7.6.2 Cipla Business Overview
7.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.6.4 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.6.5 Cipla Key News
7.7 Emcure Pharmaceuticals
7.7.1 Emcure Pharmaceuticals Corporate Summary
7.7.2 Emcure Pharmaceuticals Business Overview
7.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.7.4 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.7.5 Emcure Pharmaceuticals Key News
7.8 Flamingo Pharmaceuticals Limited
7.8.1 Flamingo Pharmaceuticals Limited Corporate Summary
7.8.2 Flamingo Pharmaceuticals Limited Business Overview
7.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.8.4 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.8.5 Flamingo Pharmaceuticals Limited Key News
7.9 Gilead Sciences
7.9.1 Gilead Sciences Corporate Summary
7.9.2 Gilead Sciences Business Overview
7.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.9.4 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.9.5 Gilead Sciences Key News
7.10 Hetero Drugs
7.10.1 Hetero Drugs Corporate Summary
7.10.2 Hetero Drugs Business Overview
7.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.10.4 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.10.5 Hetero Drugs Key News
7.11 IPCA Laboratories
7.11.1 IPCA Laboratories Corporate Summary
7.11.2 IPCA Laboratories Business Overview
7.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.11.4 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.11.5 IPCA Laboratories Key News
7.12 Janssen Pharmaceutica (Johnson & Johnson)
7.12.1 Janssen Pharmaceutica (Johnson & Johnson) Corporate Summary
7.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview
7.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.12.4 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.12.5 Janssen Pharmaceutica (Johnson & Johnson) Key News
7.13 LAURUS Labs
7.13.1 LAURUS Labs Corporate Summary
7.13.2 LAURUS Labs Business Overview
7.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.13.4 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.13.5 LAURUS Labs Key News
7.14 Medisist Pharma
7.14.1 Medisist Pharma Corporate Summary
7.14.2 Medisist Pharma Business Overview
7.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.14.4 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.14.5 Medisist Pharma Key News
7.15 Merck
7.15.1 Merck Corporate Summary
7.15.2 Merck Business Overview
7.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.15.4 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.15.5 Merck Key News
7.16 Mylan
7.16.1 Mylan Corporate Summary
7.16.2 Mylan Business Overview
7.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.16.4 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.16.5 Mylan Key News
7.17 Ranbaxy Pharmaceuticals
7.17.1 Ranbaxy Pharmaceuticals Corporate Summary
7.17.2 Ranbaxy Pharmaceuticals Business Overview
7.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.17.4 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.17.5 Ranbaxy Pharmaceuticals Key News
7.18 Shanghai Desano Pharmaceuticals
7.18.1 Shanghai Desano Pharmaceuticals Corporate Summary
7.18.2 Shanghai Desano Pharmaceuticals Business Overview
7.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.18.4 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.18.5 Shanghai Desano Pharmaceuticals Key News
7.19 ViiV Healthcare (GSK)
7.19.1 ViiV Healthcare (GSK) Corporate Summary
7.19.2 ViiV Healthcare (GSK) Business Overview
7.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Major Product Offerings
7.19.4 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global Market (2017-2022)
7.19.5 ViiV Healthcare (GSK) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Opportunities & Trends in Global Market
Table 2. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers in Global Market
Table 3. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints in Global Market
Table 4. Key Players of HIV Integrase Strand Transfer Inhibitors (INSTI) in Global Market
Table 5. Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Companies, 2017-2022
Table 8. Global Companies HIV Integrase Strand Transfer Inhibitors (INSTI) Product Type
Table 9. List of Global Tier 1 HIV Integrase Strand Transfer Inhibitors (INSTI) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Integrase Strand Transfer Inhibitors (INSTI) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2023-2028
Table 30. Adcock Ingram Limited Corporate Summary
Table 31. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 32. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 33. Affine Formulations Limited Corporate Summary
Table 34. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 35. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 36. Aurobindo Pharma Corporate Summary
Table 37. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 38. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 39. Biocon Limited Corporate Summary
Table 40. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 41. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 44. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 45. Cipla Corporate Summary
Table 46. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 47. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 48. Emcure Pharmaceuticals Corporate Summary
Table 49. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 50. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 51. Flamingo Pharmaceuticals Limited Corporate Summary
Table 52. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 53. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 54. Gilead Sciences Corporate Summary
Table 55. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 56. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 57. Hetero Drugs Corporate Summary
Table 58. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 59. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 60. IPCA Laboratories Corporate Summary
Table 61. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 62. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 63. Janssen Pharmaceutica (Johnson & Johnson) Corporate Summary
Table 64. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 65. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 66. LAURUS Labs Corporate Summary
Table 67. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 68. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 69. Medisist Pharma Corporate Summary
Table 70. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 71. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 72. Merck Corporate Summary
Table 73. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 74. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 75. Mylan Corporate Summary
Table 76. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 77. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 78. Ranbaxy Pharmaceuticals Corporate Summary
Table 79. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 80. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 81. Shanghai Desano Pharmaceuticals Corporate Summary
Table 82. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 83. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
Table 84. ViiV Healthcare (GSK) Corporate Summary
Table 85. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offerings
Table 86. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Type in 2021
Figure 2. HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Application in 2021
Figure 3. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2021
Figure 8. By Type - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 9. By Application - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 10. By Region - Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 11. By Country - North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 12. US HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 16. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 17. France HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 24. China HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 28. India HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 30. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share, 2017-2028
Figure 33. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, (US$, Mn), 2017-2028
Figure 37. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About HIV Integrase Strand Transfer Inhibitors Market

Leave This Empty: